TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT April 29, 1994